文献速递肿瘤 PET/CT

多发性骨髓瘤患者接受诱导化疗及自体造血干细胞移植时归一化FDG-PET参数的预后意义:一项回顾性单中心评估

Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-07-27

该回顾性单中心评估纳入2008年1月至2015年7月接受诱导化疗及造血干细胞移植、并有基线与治疗后FDG PET-CT的多发性骨髓瘤患者28例,分析归一化半定量参数与代谢/临床实验室缓解或进展及无进展生存的关系。结果显示代谢缓解组ΔrPET和ΔqPET显著高于代谢进展组,ΔrPET低于0.38和ΔqPET低于0.27预测更短的至代谢进展时间。

要点

  • 代谢缓解组ΔrPET中位数0.62(IQR 0.32-1.34)vs 代谢进展组0.00(IQR -0.25-0.49),P=0.045。
  • 代谢缓解组ΔqPET中位数0.51(IQR 0.32-1.13)vs 代谢进展组0.00(IQR -0.31-0.67),P=0.035。
  • ΔrPET低于0.38和ΔqPET低于0.27预测至代谢进展时间显著更短,P分别为0.003和0.005。

核心结论

  • 归一化半定量参数可有效预测接受诱导化疗及造血干细胞移植的多发性骨髓瘤患者持续治疗缓解和更短的至代谢进展时间。

研究设计与样本

  • 回顾性单中心评估,纳入2008年1月至2015年7月接受诱导化疗及造血干细胞移植、并有基线与治疗后FDG PET-CT的多发性骨髓瘤患者28例。
  • 获取基线与治疗后参数:SUVmax、SUVmean、SUVpeak、MTVsum、TLGsum、rPET(病灶SUVmax/肝脏SUVmax)和qPET(病灶SUVpeak/肝脏SUVmean),并计算基线与治疗后的变化(Δ)。
  • 记录随访时代谢与临床实验室进展或缓解,至代谢进展时间定义为治疗后扫描至随访FDG PET-CT最终进展的间隔。
  • 采用Kaplan-Meier曲线描绘按FDG PET-CT参数分组的至代谢进展时间趋势。

主要发现

  • 10例代谢缓解患者ΔrPET中位数0.62(IQR 0.32-1.34)vs 18例代谢进展患者0.00(IQR -0.25-0.49),P=0.045。
  • 10例代谢缓解患者ΔqPET中位数0.51(IQR 0.32-1.13)vs 18例代谢进展患者0.00(IQR -0.31-0.67),P=0.035。
  • 20例临床实验室缓解与8例临床实验室进展患者之间,归一化及非归一化参数均无显著差异。
  • ΔrPET低于0.38和ΔqPET低于0.27预测至代谢进展时间显著更短,P分别为0.003和0.005。

关键数值与推荐

  • ΔrPET低于0.38预测至代谢进展时间显著更短,P=0.003。
  • ΔqPET低于0.27预测至代谢进展时间显著更短,P=0.005。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to determine retrospectively, through a single-center evaluation, whether FDG PET-CT normalized semi-quantitative parameters may predict response to induction chemotherapy (iChT) and hematopoietic stem cell transplantation (HSCT), as well as disease progression and progression-free survival in multiple myeloma (MM) patients, thus becoming a tool of personalized medicine. METHODS: Patients undergoing iChT and HSCT with baseline and post-treatment FDG PET-CTs from January 2008 to July 2015 were included. The following baseline and post-treatment parameters were obtained: SUVmax, SUVmean, SUVpeak, MTVsum, TLGsum, rPET (lesion SUVmax/liver SUVmax) and qPET (lesion SUVpeak/liver SUVmean). Baseline-to-post-treatment changes (Δ) were also calculated. Metabolic and clinical laboratory progression or response at follow-up were noted; time-to-metabolic-progression (TMP) was defined as the interval from post-treatment scan to eventual progression at follow-up FDG PET-CTs. Possible association between each functional parameter and metabolic/clinical-laboratory progression or response was determined. Kaplan-Meier curves allowed to depict the TMP trend according to FDG PET-CT parameters. RESULTS: Twenty-eight patients were included. Significantly higher ΔrPET and ΔqPET values were observed in ten patients with "metabolic response", with respect to 18 patients having "metabolic progression" (median 0.62 [IQR 0.32 - 1.34] vs median 0.00 [IQR -0.25 - 0.49] for ΔrPET; P = 0.045; median 0.51 [IQR 0.32 - 1.13] vs median 0.00 [IQR -0.31 - 0.67] for ΔqPET; P = 0.035). Neither normalized nor non normalized parameters differed significantly between the 20 patients with "clinical-laboratory response" and the eight patients with "clinical-laboratory progression". ΔrPET value lower than 0.38 and ΔqPET value lower than 0.27 predicted a significantly shorter TMP (P = 0.003 and P = 0.005, respectively). CONCLUSIONS: Normalized semi-quantitative parameters are effective in predicting persistent response to treatment and shorter TMP in patients with MM undergoing iChT and HSCT.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ripani D, Caldarella C, Za T, et al. Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation. Eur J Nucl Med Mol Imaging. 2018. PMID: 30054697. doi:10.1007/s00259-018-4108-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。